Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Schell

Showing results (71-80 of 156) with videos related to

Pageof 16
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 25, 2019
Repurposing EGFR Inhibitor Utility in Colorectal Cancer in Mutant <i>APC</i> and <i>TP53</i> SubpopulationsMingli Yang, Michael J Schell, Andrey Loboda, et al.
Cancer Control : Journal of the Moffitt Cancer Center|June 13, 2015
Effect of Age on Clinical Outcomes in Phase 1 Trial ParticipantsAmit Mahipal, Aaron C Denson, Benjamin Djulbegovic, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 13, 2026
Development of an APC and TP53-based duplex sequencing assay to positively predict colorectal cancer response to anti-EGFR therapyMingli Yang, Michael J Schell, Jesse J Salk, et al.
Journal of Clinical Epidemiology|December 18, 2010
Optimism bias leads to inconclusive results-an empirical studyBenjamin Djulbegovic, Ambuj Kumar, Anja Magazin, et al.
The Journal of Biological Chemistry|November 29, 2001
Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition poreJackie F Kidd, Mary F Pilkington, Michael J Schell, et al.
International Journal of Cancer|February 3, 2005
Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinomaSatoru Kondo, Naohiro Wakisaka, Michael J Schell, et al.
Radiology|May 23, 2007
Evidence-based target recall rates for screening mammographyMichael J Schell, Bonnie C Yankaskas, Rachel Ballard-Barbash, et al.
Cancer|October 16, 2012
Phase 2 randomized study of enzastaurin (LY317615) for lung cancer prevention in former smokersJhanelle E Gray, Soner Altiok, Mark G Alexandrow, et al.
Molecular and Cellular Biology|May 25, 2011
ID1 facilitates the growth and metastasis of non-small cell lung cancer in response to nicotinic acetylcholine receptor and epidermal growth factor receptor signalingSmitha Pillai, Wasia Rizwani, Xueli Li, et al.
Oncotarget|January 6, 2017
Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechinsNagi B Kumar, Julio Pow-Sang, Philippe E Spiess, et al.
Pageof 16

Showing results (71-80 of 156) with videos related to

Sort By:
Pageof 16
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 25, 2019
Repurposing EGFR Inhibitor Utility in Colorectal Cancer in Mutant <i>APC</i> and <i>TP53</i> SubpopulationsMingli Yang, Michael J Schell, Andrey Loboda, et al.
Cancer Control : Journal of the Moffitt Cancer Center|June 13, 2015
Effect of Age on Clinical Outcomes in Phase 1 Trial ParticipantsAmit Mahipal, Aaron C Denson, Benjamin Djulbegovic, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 13, 2026
Development of an APC and TP53-based duplex sequencing assay to positively predict colorectal cancer response to anti-EGFR therapyMingli Yang, Michael J Schell, Jesse J Salk, et al.
Journal of Clinical Epidemiology|December 18, 2010
Optimism bias leads to inconclusive results-an empirical studyBenjamin Djulbegovic, Ambuj Kumar, Anja Magazin, et al.
The Journal of Biological Chemistry|November 29, 2001
Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition poreJackie F Kidd, Mary F Pilkington, Michael J Schell, et al.
International Journal of Cancer|February 3, 2005
Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinomaSatoru Kondo, Naohiro Wakisaka, Michael J Schell, et al.
Radiology|May 23, 2007
Evidence-based target recall rates for screening mammographyMichael J Schell, Bonnie C Yankaskas, Rachel Ballard-Barbash, et al.
Cancer|October 16, 2012
Phase 2 randomized study of enzastaurin (LY317615) for lung cancer prevention in former smokersJhanelle E Gray, Soner Altiok, Mark G Alexandrow, et al.
Molecular and Cellular Biology|May 25, 2011
ID1 facilitates the growth and metastasis of non-small cell lung cancer in response to nicotinic acetylcholine receptor and epidermal growth factor receptor signalingSmitha Pillai, Wasia Rizwani, Xueli Li, et al.
Oncotarget|January 6, 2017
Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechinsNagi B Kumar, Julio Pow-Sang, Philippe E Spiess, et al.
Pageof 16